Samsung Biologics (KRX: 207940.KS) has announced an all-cash public tender offer to acquire 100% of the fully diluted share capital ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE